Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,070.00
Bid: 3,088.00
Ask: 3,090.00
Change: 36.00 (1.19%)
Spread: 2.00 (0.065%)
Open: 3,046.00
High: 3,092.00
Low: 3,046.00
Prev. Close: 3,034.00
BNZL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

15 Jun 2023 07:00

RNS Number : 7594C
Bunzl PLC
15 June 2023
 

15 June 2023

 

BUNZL PRE-CLOSE STATEMENT

 

Bunzl plc, the specialist international distribution and services Group, is updating the market today prior to entering its closed period for the six months ending 30 June 2023.

 

The Group is expected to deliver another resilient performance, with Group revenue in the first half expected to increase year-on-year by 4% to 5% at actual exchange rates, and to grow by up to 1% at constant exchange rates. Growth at constant exchange rates is expected to be driven by acquisitions, although partially offset by the impact of the UK healthcare disposal, and with underlying revenue growth expected to be broadly flat1. Group adjusted operating margin for the first half is expected to be around the level achieved in the first half of 2022.

 

Underlying revenue in North America is expected to decline moderately, driven by volume weakness in our foodservice sector, some of which is anticipated to be temporary, and with reducing benefit from inflation over the period. Inflation is expected to drive good underlying revenue growth in Continental Europe and strong growth in UK & Ireland. Underlying revenue growth in Rest of the World is expected to be impacted by a decline in Covid-19 related sales.

 

At constant exchange rates the Group continues to expect revenue in 2023 to be slightly higher than in 2022, driven by both organic growth and announced acquisitions, and partially offset by a small impact from the UK healthcare disposal. Given performance year-to-date, the Group is increasing its 2023 operating margin guidance to be slightly lower than that achieved over 2022.

 

The Group also announces today that it has entered into an agreement to acquire EHM, a distributor of a wide range of PPE products in the UK, which is complementary to our existing safety business. The business generated revenue in 2022 of £18 million.

 

Commenting on today's announcement, Frank van Zanten, Chief Executive Officer of Bunzl, said:

 

"Bunzl continues to demonstrate resilience, with our operating margin over the first six months of the year expected to remain well ahead of historical levels and driving an upgrade to our full year expectations. Our acquisition momentum remains strong, with the acquisition of EHM, announced today, enhancing our safety offering in the UK. Year-to-date we have announced six acquisitions, including Bunzl's 200th since 2004, with our pipeline remaining active and supported by a strong balance sheet.

 

Insight event:

On 29 June 2023, Bunzl will be holding a North America insight event for investors. The virtual event will be hosted by Jim McCool, our CEO of North America, and he will be joined by the Managing Directors leading our safety, food processor and agriculture businesses in the region. The event will be live from 3pm - 4.15pm BST. Registration details are available on www.bunzl.com.

 

Note:

1. The number of trading days will not have an impact on growth over the first half period overall. 

 

Enquiries:

Bunzl plc

Frank van Zanten, Chief Executive Officer

Richard Howes, Chief Financial Officer

Sunita Entwisle, Head of Investor Relations

Tel: +44 (0)20 7725 5000

Teneo

Martin Robinson

Olivia Peters

Tel: +44 (0)20 7353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBLGDLBSBDGXS
Date   Source Headline
25th Apr 20244:45 pmRNSDirector/PDMR Shareholding
24th Apr 20242:51 pmRNSResult of AGM
24th Apr 20247:00 amRNSTrading Statement
22nd Apr 20244:36 pmRNSDirector/PDMR Shareholding
18th Apr 20248:00 amRNSAdditional Listing
11th Apr 20248:00 amRNSAdditional Listing
3rd Apr 20245:28 pmRNSDirector/PDMR Shareholding
3rd Apr 20249:09 amRNSDirector/PDMR Shareholding
2nd Apr 20241:50 pmRNSTotal Voting Rights
21st Mar 20248:00 amRNSAdditional Listing
15th Mar 20243:28 pmRNSAnnual Financial Report
7th Mar 20248:00 amRNSAdditional Listing
5th Mar 20245:05 pmRNSDirector/PDMR Shareholding
4th Mar 20243:03 pmRNSDirector/PDMR Shareholding
1st Mar 202411:35 amRNSTotal Voting Rights
28th Feb 20243:17 pmRNSDirector/PDMR Shareholding
27th Feb 20245:26 pmRNSDirector/PDMR Shareholding
26th Feb 202410:30 amRNSDividend Declaration
26th Feb 20247:00 amRNSFinal Results
26th Feb 20247:00 amRNSAcquisition
5th Feb 20242:20 pmRNSDirector/PDMR Shareholding
1st Feb 20245:08 pmRNSTotal Voting Rights
12th Jan 20244:54 pmRNSDirector/PDMR Shareholding
11th Jan 20243:50 pmRNSDirector/PDMR Shareholding
2nd Jan 202410:57 amRNSTotal Voting Rights
15th Dec 20235:10 pmRNSHolding(s) in Company
14th Dec 20237:00 amRNSTrading Statement
8th Dec 20235:32 pmRNSDirector/PDMR Shareholding
1st Dec 202311:32 amRNSTotal Voting Rights
20th Nov 20236:30 pmRNSPublication of Admission Particulars
3rd Nov 20239:30 amRNSDirector Declaration
2nd Nov 20232:29 pmRNSDirector/PDMR Shareholding
1st Nov 202311:24 amRNSTotal Voting Rights
1st Nov 20239:00 amRNSBlock listing Interim Review
24th Oct 20237:00 amRNSTrading Statement
6th Oct 20235:08 pmRNSDirector/PDMR Shareholding
4th Oct 20231:40 pmRNSDirector/PDMR Shareholding
2nd Oct 20231:34 pmRNSTotal Voting Rights
2nd Oct 20231:33 pmRNSDirector/PDMR Shareholding
26th Sep 20232:10 pmRNSDirector/PDMR Shareholding
1st Sep 20232:30 pmRNSTotal Voting Rights
31st Aug 202310:30 amRNSDirector/PDMR Shareholding
29th Aug 202310:00 amRNSDividend Declaration
29th Aug 20237:00 amRNSHalf-year Report
29th Aug 20237:00 amRNSAcquisition
15th Aug 20237:00 amRNSAcquisition
2nd Aug 20233:45 pmRNSDirector/PDMR Shareholding
1st Aug 202311:17 amRNSTotal Voting Rights
13th Jul 20234:20 pmRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSOutcome of audit tender process

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.